VYNE Therapeutics Inc (VYNE)
2.62
+0.12
(+4.80%)
USD |
NASDAQ |
May 03, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
VYNE Therapeutics Price: 2.62 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.54 | 2.768 | 2.53 | 2.62 | 34681.00 |
May 02, 2024 | 2.53 | 2.53 | 2.40 | 2.50 | 29242.00 |
May 01, 2024 | 2.50 | 2.57 | 2.50 | 2.53 | 83588.00 |
Apr 30, 2024 | 2.61 | 2.61 | 2.40 | 2.52 | 39454.00 |
Apr 29, 2024 | 2.54 | 2.63 | 2.530 | 2.63 | 19253.00 |
Apr 26, 2024 | 2.53 | 2.575 | 2.42 | 2.50 | 15899.00 |
Apr 25, 2024 | 2.52 | 2.80 | 2.41 | 2.47 | 77467.00 |
Apr 24, 2024 | 2.40 | 2.730 | 2.295 | 2.57 | 384779.0 |
Apr 23, 2024 | 2.31 | 2.36 | 2.240 | 2.32 | 30376.00 |
Apr 22, 2024 | 2.24 | 2.43 | 2.24 | 2.35 | 27675.00 |
Apr 19, 2024 | 2.26 | 2.34 | 2.25 | 2.25 | 18999.00 |
Apr 18, 2024 | 2.39 | 2.39 | 2.25 | 2.30 | 11098.00 |
Apr 17, 2024 | 2.333 | 2.50 | 2.333 | 2.40 | 31265.00 |
Apr 16, 2024 | 2.50 | 2.50 | 2.38 | 2.42 | 33106.00 |
Apr 15, 2024 | 2.85 | 2.85 | 2.43 | 2.57 | 58530.00 |
Apr 12, 2024 | 2.93 | 2.93 | 2.688 | 2.77 | 28561.00 |
Apr 11, 2024 | 2.67 | 3.020 | 2.56 | 3.00 | 104623.0 |
Apr 10, 2024 | 2.70 | 2.84 | 2.55 | 2.68 | 60847.00 |
Apr 09, 2024 | 2.755 | 2.80 | 2.69 | 2.76 | 28419.00 |
Apr 08, 2024 | 2.78 | 2.816 | 2.65 | 2.74 | 71401.00 |
Apr 05, 2024 | 2.86 | 2.97 | 2.76 | 2.83 | 75932.00 |
Apr 04, 2024 | 3.06 | 3.11 | 2.81 | 2.84 | 430435.0 |
Apr 03, 2024 | 3.00 | 3.10 | 2.99 | 3.10 | 53581.00 |
Apr 02, 2024 | 3.14 | 3.14 | 2.914 | 3.02 | 128663.0 |
Apr 01, 2024 | 3.13 | 3.17 | 3.01 | 3.08 | 195693.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.71
Minimum
Jan 31 2024
504.00
Maximum
May 06 2019
99.00
Average
22.68
Median
Oct 04 2021
Price Benchmarks
Viking Therapeutics Inc | 76.97 |
AN2 Therapeutics Inc | 2.56 |
NovaBay Pharmaceuticals Inc | 0.0949 |
Palatin Technologies Inc | 2.11 |
iBio Inc | 1.99 |
Price Related Metrics
PS Ratio | 36.94 |
Price to Book Value | 0.4163 |
Earnings Yield | -277.8% |
Market Cap | 36.94M |